Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Diabetes

Looking back at Look AHEAD—giving lifestyle a chance

The Look AHEAD trial did not show that a lifestyle modification programme aimed at weight loss could reduce the incidence of cardiovascular disease events. We attempt to address why this trial was 'negative', and emphasize that further randomized lifestyle modification trials focusing on the effects of physical activity and exercise are needed.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. US Department of Health and Human Services. National Institutes of Health. Weight loss does not lower heart disease risk from type 2 diabetes [online], (2012).

  2. Ryan, D. H. et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control. Clin. Trials 24, 610–628 (2003).

    Article  Google Scholar 

  3. Pi-Sunyer, X. et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 30, 1374–1383 (2007).

    Article  Google Scholar 

  4. Wadden, T. A. et al. Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) 19, 1987–1998 (2011).

    Article  Google Scholar 

  5. Brancati, F. L. et al. Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study. Clin. Trials 9, 113–124 (2012).

    Article  Google Scholar 

  6. Das, P. & Horton, R. Rethinking our approach to physical activity. Lancet 380, 189–190 (2012).

    Article  Google Scholar 

  7. Mozaffarian, D. Achieving cardiovascular health: a bleak outlook or tremendous potential? J. Am. Coll. Cardiol. 57, 1697–1699 (2011).

    Article  Google Scholar 

  8. Tuomilehto, J. Nonpharmacologic therapy and exercise in the prevention of type 2 diabetes. Diabetes Care 32 (Suppl. 2), S189–S193 (2009).

    Article  Google Scholar 

  9. Gregg, E. W. et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308, 2489–2496 (2012).

    Article  CAS  Google Scholar 

  10. Unger, R. H., Clark, G. O., Scherer, P. E. & Orci, L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 1801, 209–214 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Pierre Després.

Ethics declarations

Competing interests

J.-P. Després has received honoraria as a speaker for Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Merck, and Pfizer Canada, and as an Advisory Board member of Novartis, Theratechnologies, and Torrent Pharmaceuticals. P. Poirier declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Després, JP., Poirier, P. Looking back at Look AHEAD—giving lifestyle a chance. Nat Rev Cardiol 10, 184–186 (2013). https://doi.org/10.1038/nrcardio.2013.16

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2013.16

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing